Stocks TelegraphStocks Telegraph
Stock Ideas

OMCL Company Profile and Key Details

NASDAQ : OMCL

Omnicell

$39.08
-7.61-16.30%
At Close 4:00 PM
$44.88
+5.80+14.84%
After-Market 08:30 PM
67.59
BESG ScoreESG Rating

Price Chart

Stock Price Today

Omnicell, Inc. (OMCL) stock declined over -16.30%, trading at $39.08 on NASDAQ, down from the previous close of $46.69. The stock opened at $39.69, fluctuating between $36.95 and $41.52 in the recent session.

Stock Snapshot

46.69
Prev. Close
1.8B
Market Cap
36.95
Day Low
90.88
P/E Ratio
0.43
EPS (TTM)
2.77
Cash Flow per Share
39.69
Open
45.93M
Number of Shares
41.52
Day High
97.58%
Free Float in %
26.13
Book Value
2.84M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 05, 202639.6941.5636.9439.082.84M
Feb 04, 202648.2450.1945.9446.691.91M
Feb 03, 202648.7349.0545.1046.04775.6K
Feb 02, 202649.0950.1448.5448.70656.84K
Jan 30, 202648.7249.3948.1848.50374.85K
Jan 29, 202649.0649.4148.0549.09361.94K
Jan 28, 202650.2850.7048.5549.04413.69K
Jan 27, 202650.2250.5049.6049.96197.17K
Jan 26, 202650.3051.0050.0750.32430.54K
Jan 23, 202651.0151.1449.8750.30270.85K
Jan 22, 202650.5151.4050.4051.32359.26K
Jan 21, 202649.5750.6749.1250.48289.22K
Jan 20, 202650.4150.7548.8249.06323.74K
Jan 16, 202650.8251.3050.4550.52367.82K
Jan 15, 202650.6951.2550.0750.98414.31K
Jan 14, 202651.3451.3449.9050.72722.01K
Jan 13, 202651.7655.0050.3751.39301.91K
Jan 12, 202650.4851.3049.0051.19386.31K
Jan 09, 202650.2151.3049.9350.74460.23K
Jan 08, 202649.9051.0949.6850.59836.38K

Contact Details

Mountain View, CA 94043

United States

https://www.omnicell.com650 251 6100

About Company

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

Company Information

Employees3620
Beta0.78
Sales or Revenue$1.15B
5Y Sales Change%0.265%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Healthcare Information Services

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 -20.63%, SMA50 -14.25%, SMA200 13.51%). The stock’s 14-day RSI is 25.03 (weak momentum), while the ATR of 2.4 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -24.61% below its high and over 72.46% above its low. Average 10-day trading volume of 941.98 thousand shares is significantly above the 3-month average of 553.41 thousand, indicating heightened recent market interest.

Earnings & Analyst Outlook

Omnicell, Inc. generated EPS of $0.43 over the past year. Five-year average earnings growth is -28.29%. Wall Street analysts project EPS growth of 7.81% annually over the next five years. The latest quarter delivered EPS of $0.12. The next quarter is forecast at $0.50. Next year's EPS is expected at $0.54. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 3 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $60.00 to $36.00. The high target offers 53.53% upside. The low target suggests -7.88% downside. The mean target is $49.75. This offers 27.3% upside. Omnicell, Inc. earnings surprise history is a mixed track record. The quarter that ended October 30, 2025, missed forecasts by -67.47%. The prior quarter beat by 45.16%. Over the last six quarters, Apple has recorded several small beats. These include -49.29% in August 01, 2024.

Shareholding & Insider Activity

Omnicell, Inc. has 45.93 million shares outstanding. The public float is 44.82 million shares, elevated short interest at 6.42% of float. This equals 2.04 million shares. The short ratio is 4.15 days. Institutional investors hold 107.65% of the float. Insiders own 1.79%. LIPPS RANDALL A holds 386.65 thousand shares, Manley Corey J has 91.67 thousand shares and Kuipers Peter J. has 61.33 thousand shares. Over the past six months, insider transactions show net selling. They sold 48.09 thousand shares across 6 transactions.

Frequently Asked Questions

What is the current Omnicell, Inc. (OMCL) stock price?
Omnicell, Inc. (NASDAQ: OMCL) stock price is $39.08 in the last trading session. During the trading session, OMCL stock reached the peak price of $41.52 while $36.95 was the lowest point it dropped to. The percentage change in OMCL stock occurred in the recent session was -16.3% while the dollar amount for the price change in OMCL stock was - $7.61.
OMCL's industry and sector of operation?
The NASDAQ listed OMCL is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Omnicell, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of OMCL?
Mr. Giri Chodavarapu
Senior Vice President & Chief Information Officer
Ms. Kathleen Nemeth
Senior Vice President of Investor Relations
Ms. Christine Mellon
Executive Vice President, Chief Admin. & People Officer
Ms. Roxanne Turner
Senior Vice President of Corporation Responsibility and Chief Compliance & Privacy Officer
Mr. Jorge R. Taborga
Executive Vice President of Engineering & Integration Management Officer
Mr. Virad Gupta
Senior Vice President & Chief Technology Officer
Mr. Joseph Brian Spears
Senior Vice President, Chief Accounting Officer & Corporation Controller
Mr. Randall A. Lipps
Founder, Executive Chairman, Pres & Chief Executive Officer
Mr. Scott Peter Seidelmann
Executive Vice President & Chief Commercial Officer
Mr. Nchacha Etta
Executive Vice President & Chief Financial Officer
Ms. Christine M. Mellon
Executive Vice President & Chief Admin. Officer
Mr. Corey J. Manley
Executive Vice President and Chief Legal & Admin. Officer
Mr. Peter J. Kuipers
Executive Adviser
Ms. Minoo Mortazavi
Senior Vice President of Global Operations
Mr. Maximo Rocha
Senior Vice President & Chief People Officer
How OMCL did perform over past 52-week?
OMCL's closing price is 72.46% higher than its 52-week low of $22.66 where as its distance from 52-week high of $55.00 is -28.95%.
How many employees does OMCL have?
Number of OMCL employees currently stands at 3,620.
Link for OMCL official website?
Official Website of OMCL is: https://www.omnicell.com
How do I contact OMCL?
OMCL could be contacted at phone 650 251 6100 and can also be accessed through its website. OMCL operates from 590 East Middlefield Road, Mountain View, CA 94043, United States.
How many shares of OMCL are traded daily?
OMCL stock volume for the day was 2.84M shares. The average number of OMCL shares traded daily for last 3 months was 534.25K.
What is the market cap of OMCL currently?
The market value of OMCL currently stands at $1.80B with its latest stock price at $39.08 and 45.93M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph